CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Details 4) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net cash provided by (used in) operating activities	$ 106,248	$ 133,504
Cash flows from investing activities:
Capital expenditures	(115,208)	(104,695)
Investments in non-consolidated entities, net	(1,060)	(2,766)
Acquisition of Rave theatres, net of cash acquired		(1,128)
Proceeds from the disposition of long-term assets	9	4,866
Other, net	1,540	(4,677)
Net cash used in investing activities	(114,719)	(108,400)
Cash flows from financing activities:
Proceeds from issuance of Senior Subordinated Notes due 2022	375,000
Repurchase of Senior Subordinated Notes due 2019	(639,728)
Payment of initial public offering costs	(281)
Cash used to pay dividends to parent	(19,489)
Proceeds from issuance of Term Loan due 2020		773,063
Repayment of Term Loan due 2016		(464,088)
Repayment of Term Loan due 2018		(296,250)
Deferred financing costs	(7,874)	(8,111)
Principal payments under capital and financing lease obligations	(3,388)	(3,064)
Principal payments under Term Loan	(3,875)	(3,939)
Principal amount of coupon payment under Senior Subordinated Notes due 2020	(3,052)
Payment of construction payables		(19,404)
Net cash used in financing activities	(302,687)	(21,793)
Effect of exchange rate changes on cash and equivalents	9	(75)
Net increase (decrease) in cash and equivalents	(311,149)	3,236
Cash and equivalents at beginning of period	544,311	130,928
Cash and equivalents at end of period	233,162	134,164
AMCE | Reportable Entity
Cash flows from operating activities:
Net cash provided by (used in) operating activities	4,992	1,195
Cash flows from financing activities:
Proceeds from issuance of Senior Subordinated Notes due 2022	375,000
Repurchase of Senior Subordinated Notes due 2019	(639,728)
Cash used to pay dividends to parent	(19,489)
Proceeds from issuance of Term Loan due 2020		773,063
Repayment of Term Loan due 2016		(464,088)
Repayment of Term Loan due 2018		(296,250)
Deferred financing costs	(7,874)	(8,111)
Principal payments under Term Loan	(3,875)	(3,939)
Principal amount of coupon payment under Senior Subordinated Notes due 2020	(3,052)
Change in intercompany advances	294,104	(2,002)
Net cash used in financing activities	(4,914)	(1,327)
Net increase (decrease) in cash and equivalents	78	(132)
Cash and equivalents at beginning of period	485	308
Cash and equivalents at end of period	563	176
Subsidiary Guarantors | Reportable Entity
Cash flows from operating activities:
Net cash provided by (used in) operating activities	103,835	129,215
Cash flows from investing activities:
Capital expenditures	(115,183)	(104,687)
Investments in non-consolidated entities, net	(1,060)	(2,781)
Acquisition of Rave theatres, net of cash acquired		(1,128)
Proceeds from the disposition of long-term assets	9	4,866
Other, net	1,540	(4,677)
Net cash used in investing activities	(114,694)	(108,407)
Cash flows from financing activities:
Payment of initial public offering costs	(281)
Principal payments under capital and financing lease obligations	(3,388)	(3,064)
Payment of construction payables		(19,404)
Change in intercompany advances	(295,869)	4,937
Net cash used in financing activities	(299,538)	(17,531)
Effect of exchange rate changes on cash and equivalents	(540)	(57)
Net increase (decrease) in cash and equivalents	(310,937)	3,220
Cash and equivalents at beginning of period	501,989	89,168
Cash and equivalents at end of period	191,052	92,388
Subsidiary Non-Guarantors | Reportable Entity
Cash flows from operating activities:
Net cash provided by (used in) operating activities	(2,579)	3,094
Cash flows from investing activities:
Capital expenditures	(25)	(8)
Investments in non-consolidated entities, net		15
Net cash used in investing activities	(25)	7
Cash flows from financing activities:
Change in intercompany advances	1,765	(2,935)
Net cash used in financing activities	1,765	(2,935)
Effect of exchange rate changes on cash and equivalents	549	(18)
Net increase (decrease) in cash and equivalents	(290)	148
Cash and equivalents at beginning of period	41,837	41,452
Cash and equivalents at end of period	$ 41,547	$ 41,600